| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
| 01/06/2005 | US20050004199 Treatment of inflammation with a combination of a cyclooxygenase-2 inhibitor and an integrin alpha-v antagonist |
| 01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
| 01/06/2005 | US20050004191 Crystallization production of form II; yield, low cost; does not requires rapid cooling |
| 01/06/2005 | US20050004180 Conditions mediated by beta chemokine receptor 2, monocyte chemotactic protein 1 and/or their interaction; such as 4-acetyl-5-cyclohexyl-3-amino-1-(4-methylphenyl)-1,5-dihydro-2H-pyrrol-2-one |
| 01/06/2005 | US20050004177 Joint cartilage damage, inflammation, stiffness, impaired function and/or pain; osteoarthritis, rheumatoid arthritis |
| 01/06/2005 | US20050004175 Xanthine oxidase inhibitors; hyperuricemia and gout; such as 3-(4-isobutoxy-3-nitrophenyl)-5-(2-methyl-4-pyridyl)-1,2,4-triazole |
| 01/06/2005 | US20050004153 inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); use treating transplant rejection, rheumatoid arthritis, diabetes, inflammatory bowel disease, and chronic obstructive pulmonary disease; 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes |
| 01/06/2005 | US20050004149 Pyrimidine compound and medicinal composition thereof |
| 01/06/2005 | US20050004142 furo(2,3-d)pyrimidine and thieno(2,3-d)pyrimidine compounds for treating cancer and hyperproliferative diseases; receptor tyrosine kinase inhibitors |
| 01/06/2005 | US20050004140 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states |
| 01/06/2005 | US20050004135 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 01/06/2005 | US20050004134 Adenosine antagonists; having 6-oxo-1,6-dihydro-3-pynidazinyl functionality; synthesis |
| 01/06/2005 | US20050004132 Pain, immune diseases, inflammatory disorders; low toxicity; such as 1-[2-(3-(4-Pyridyl)phenyl)ethyl]-4-(3-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine 1-oxide |
| 01/06/2005 | US20050004126 Method of determining potential allosterically-binding matrix metalloproteinase inhibitors |
| 01/06/2005 | US20050004120 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 01/06/2005 | US20050004116 Triazole inhibitors of type 2 methionine aminopeptidase |
| 01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 01/06/2005 | US20050004108 Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degenaration |
| 01/06/2005 | US20050004089 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 01/06/2005 | US20050004073 Pharmaceutical composition comprising chito-oligomers |
| 01/06/2005 | US20050004061 Immunostimulatory nucleic acid molecules |
| 01/06/2005 | US20050004056 Ptp10d, tec protein tyrosine kinase and edtp homologous proteins involved in the regulation of energy homeostasis |
| 01/06/2005 | US20050003473 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 01/06/2005 | US20050003457 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders |
| 01/06/2005 | US20050003400 Using osteoprotegrin binding agent as tool in identifying modulator for treatment and prevention of osteoporosis and bone disorders |
| 01/06/2005 | US20050003370 Expression vector comprising nucleotide sequences coding membrane receptor proteins for use in identifying modulators for treatment and prevention of cell proliferative, nervous system, reproductive cardiovascular and inflammation disorders |
| 01/06/2005 | US20050002950 Vaccine preventing infection |
| 01/06/2005 | US20050002909 Methods and compositions for treating intervertebral disc degeneration |
| 01/06/2005 | CA2530631A1 Use of bacilli-class bacteria to produce a composition for the prevention of vertebral compression syndrome in salmonids |
| 01/06/2005 | CA2529468A1 N-{[4-substituted piperazine-1-sulfonylmethyl]alkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors |
| 01/06/2005 | CA2525928A1 A method of treating degenerative disc disease |
| 01/05/2005 | EP1493743A1 Substituted bipiperidine intermediates and derivatives thereof |
| 01/05/2005 | EP1493741A2 Benzo[b]thiophene compounds, intermediates, processes, compositions and methods |
| 01/05/2005 | EP1493740A1 5-fluoro-thiophene compounds, the process for their prepartion, the pharmaceutical compositions containing them and their use as metalloproteinases inhibitors |
| 01/05/2005 | EP1493738A1 Epothilone derivatives |
| 01/05/2005 | EP1492797A1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof |
| 01/05/2005 | EP1492795A1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 01/05/2005 | EP1492787A2 (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them |
| 01/05/2005 | EP1492780A1 5-substituted 1,1-dioxo-[1,2,5]thiazolidine-3-one derivatives as ptpase 1b inhibitors |
| 01/05/2005 | EP1492778A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors |
| 01/05/2005 | EP1492777A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidase inhibitors |
| 01/05/2005 | EP1492775A2 Oxo-azabicyclic compounds |
| 01/05/2005 | EP1492774A2 Pyrimidone derivatives useful for the treatment of inflammation and immunological diseases |
| 01/05/2005 | EP1492773A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| 01/05/2005 | EP1492771A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 01/05/2005 | EP1492761A2 Amino acids with affinity for the alpha-2-delta-protein |
| 01/05/2005 | EP1492757A1 (2-((2-alkoxy)-phenyl)-cyclopent-1-enyl) aromatic carbo- and heterocyclic carboxylic acid and derivatives |
| 01/05/2005 | EP1492543A1 Drugs for the arthritis treatment |
| 01/05/2005 | EP1492542A1 Hormone replacement therapy |
| 01/05/2005 | EP1492538A1 Meloxicam suppositories containing e.g. polyethylenglycol |
| 01/05/2005 | EP1492533A1 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis |
| 01/05/2005 | EP1492530A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors |
| 01/05/2005 | EP1492508A1 Controlled release dosage forms |
| 01/05/2005 | EP1492502A1 Novel polymorphs and pseudopolymorphs of risedronate sodium |
| 01/05/2005 | EP1248630B9 Use of a dermatological composition containing oligosaccharides for the treatment of skin diseases |
| 01/05/2005 | EP1227814B1 Hormonal composition based on nomegestrol acetate and an oestrogen and use thereof |
| 01/05/2005 | EP1226126B1 Pyrimidine derivatives |
| 01/05/2005 | DE19957065B4 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 01/05/2005 | CN1561390A PEG-modified uricase |
| 01/05/2005 | CN1561387A Probiotic bifidobacterium strains |
| 01/05/2005 | CN1561344A Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 01/05/2005 | CN1561340A Novel 1, 2, 4-triazole compound |
| 01/05/2005 | CN1561334A Indole derivatives as COXII inhibitors |
| 01/05/2005 | CN1561327A Novel aminobenzoephenones |
| 01/05/2005 | CN1561235A Device having osteoinductive and osteoconductive properties |
| 01/05/2005 | CN1561226A Use of the long pentraxin PTX3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 01/05/2005 | CN1561223A New drug |
| 01/05/2005 | CN1561222A Matrix metalloprotease inhibitor |
| 01/05/2005 | CN1561219A Pharmaceutical compounds |
| 01/05/2005 | CN1561216A Novel compounds |
| 01/05/2005 | CN1561215A Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid compounds used as nmda antagonist |
| 01/05/2005 | CN1561201A Pharmaceutical compositions comprising colloidal silicon dioxide |
| 01/05/2005 | CN1561199A Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 01/05/2005 | CN1561197A Method for producing biologically active products |
| 01/05/2005 | CN1560249A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 01/05/2005 | CN1560051A 取代吡唑化合物 A substituted pyrazole compound |
| 01/05/2005 | CN1560041A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 01/05/2005 | CN1559589A Medicinal liquid for treating osteoporosis and its preparation method |
| 01/05/2005 | CN1559581A External use medicine for bone-knitting |
| 01/05/2005 | CN1559569A Chinese medicne plaster for bone injury and its preparation method |
| 01/05/2005 | CN1559566A Fengtongning Chinese medicinal preparaton and its preparation method |
| 01/05/2005 | CN1559557A External-used powder for treating rheumatism and hyperosteogeny |
| 01/05/2005 | CN1559555A Adhesive plaster for treating pain of shoulder |
| 01/05/2005 | CN1559550A New type medicina preparation with one chinese medicinal herb extract ant its preparation method |
| 01/05/2005 | CN1559547A Bone fracture, injury capsule and its manufacturing method |
| 01/05/2005 | CN1559546A Insensitive impediment capsule and its manufacturing method |
| 01/05/2005 | CN1559544A Cervical vertebra disease capsule and its manufacturing method |
| 01/05/2005 | CN1559543A Traumatic injury capsule and its manufacturing method |
| 01/05/2005 | CN1559542A Immune balancing energy restoring ointment and its manufacturing method |
| 01/05/2005 | CN1559540A Bone joint disease capsule and its manufacturing metod |
| 01/05/2005 | CN1559534A Polylactic acid microglobule Chinese medicine compound for mula used for treating bone arthritis and its preparation method |
| 01/05/2005 | CN1559533A Toxicity expelling wind damping joint curing wine |
| 01/05/2005 | CN1559531A Medicine for treating burn and its use method |
| 01/05/2005 | CN1559519A Prunella spike extract and its preparation method and use |
| 01/05/2005 | CN1559507A Fumigant |
| 01/05/2005 | CN1559496A Chinese medicine preparation of removing obstruction in the channels for treating atrophic arthritis |
| 01/05/2005 | CN1559487A Health-care spray for treating acute injury, chronic strain, rheumatalgia |
| 01/05/2005 | CN1559486A Health-care medicinal plaster used for preventing and curing discopathy, osteosis, ischialgia |
| 01/05/2005 | CN1559484A Medicinal plaster for treating ischemic necrosis of femer head and its preparation method |